News

AevisBio entered into a collaborative research with KRISS

관리자 │ 2023-10-13

HIT

185

In June of 2020, AevisBio and Korea Research Institute of Standards and Science (KRISS) announced a collaboration to develop technologies for treating infectious disease especially focused on COVID19.  
목록

이전글 Awarded two post-TIPS grants (₩1B each) from Ministry of SMEs and Startups (Ko...
다음글 Korean Government grant awarded from NRF